Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tia Bimal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
JACC. Case Reports|November 1, 2024
Life-Threatening Reaction to Lifesaving Medication: Stepwise Approach to Severe Adverse Reactions to PCSK-9 Monoclonal AntibodiesTia Bimal, Anthony Szema, Maia Pavlovic, et al.
Cureus|September 9, 2022
A Peculiar Case of Fentanyl-Induced CardiomyopathyFaraz Badar, Aqsa Ashraf, Md R Bhuiyan, et al.
The Journal of Innovations in Cardiac Rhythm Management|September 8, 2022
A Case of Bundle Branch Re-entrant Ventricular Tachycardia 1 Year After Transcatheter Aortic Valve ReplacementAmarbir Bhullar, Nikhil Sharma, Rosaline Ma, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 19, 2023
Percutaneous coronary intervention with Impella support with and without intra-aortic balloon in cardiogenic shock patientsRefayat Bhuiyan, Tia Bimal, Joanna Fishbein, et al.
Atherosclerosis|March 18, 2026
Association of Lp(a) with coronary plaque burden and high-risk plaque features: A meta-analysis of imaging studiesSneha Annie Sebastian, Tia Bimal, Tanesh Ayyalu, et al.
Disease-A-Month : DM|November 27, 2025
Patient-accessible continuous glucose monitoring for cardiometabolic risk reduction in type 2 diabetes: A meta-analysis of randomized controlled trialsSneha Annie Sebastian, Inderbir Padda, Tia Bimal, et al.
Disease-A-Month : DM|March 20, 2026
Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysisSneha Annie Sebastian, Tanesh Ayyalu, Tia Bimal, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 21, 2023
The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary interventionTia Bimal, Md Refayat Bhuiyan, Joanna Fishbein, et al.
JACC. Case Reports|April 18, 2025
Inadequate Response to PCSK9 InhibitorsTia Bimal, Tanesh Ayyalu, Maya S Safarova, et al.
American Journal of Preventive Cardiology|July 29, 2024
Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyondMaya Safarova, Tia Bimal, Daniel E Soffer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
JACC. Case Reports|November 1, 2024
Life-Threatening Reaction to Lifesaving Medication: Stepwise Approach to Severe Adverse Reactions to PCSK-9 Monoclonal AntibodiesTia Bimal, Anthony Szema, Maia Pavlovic, et al.
Cureus|September 9, 2022
A Peculiar Case of Fentanyl-Induced CardiomyopathyFaraz Badar, Aqsa Ashraf, Md R Bhuiyan, et al.
The Journal of Innovations in Cardiac Rhythm Management|September 8, 2022
A Case of Bundle Branch Re-entrant Ventricular Tachycardia 1 Year After Transcatheter Aortic Valve ReplacementAmarbir Bhullar, Nikhil Sharma, Rosaline Ma, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 19, 2023
Percutaneous coronary intervention with Impella support with and without intra-aortic balloon in cardiogenic shock patientsRefayat Bhuiyan, Tia Bimal, Joanna Fishbein, et al.
Atherosclerosis|March 18, 2026
Association of Lp(a) with coronary plaque burden and high-risk plaque features: A meta-analysis of imaging studiesSneha Annie Sebastian, Tia Bimal, Tanesh Ayyalu, et al.
Disease-A-Month : DM|November 27, 2025
Patient-accessible continuous glucose monitoring for cardiometabolic risk reduction in type 2 diabetes: A meta-analysis of randomized controlled trialsSneha Annie Sebastian, Inderbir Padda, Tia Bimal, et al.
Disease-A-Month : DM|March 20, 2026
Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysisSneha Annie Sebastian, Tanesh Ayyalu, Tia Bimal, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 21, 2023
The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary interventionTia Bimal, Md Refayat Bhuiyan, Joanna Fishbein, et al.
JACC. Case Reports|April 18, 2025
Inadequate Response to PCSK9 InhibitorsTia Bimal, Tanesh Ayyalu, Maya S Safarova, et al.
American Journal of Preventive Cardiology|July 29, 2024
Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyondMaya Safarova, Tia Bimal, Daniel E Soffer, et al.
Pageof 2